Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3977337 | Brachytherapy | 2011 | 7 Pages |
Abstract
Younger men and those with more aggressive pretreatment clinical factors were more likely to receive trimodality treatment in this community cohort of men with high-risk prostate cancer. Selection for trimodality use varied significantly by site indicating a need for treatment standardization in the community.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Jona A. Hattangadi, Ming-Hui Chen, Michelle H. Braccioforte, Brian J. Moran, Anthony V. D'Amico,